Takeda
Bristol Myers Squibb, LabCorp, NeoGenomics, Others Join Consortium to Improve COVID-19 Testing
The consortium seeks to accelerate research and clinical diagnostic applications through collaboration with the ultimate goal of improving COVID-19 testing.
Foundation Medicine, Takeda Collaborate to Develop CDx for NSCLC Therapies
The tests will be developed to identify NSCLC patients with ALK fusions and EGFR Exon20 insertion mutations who respond to mobocertinib or brigatinib.
Takeda's Alunbrig Gets First-Line FDA Approval With Abbott CDx in ALK-Positive Lung Cancer
The approval was based on data showing superior efficacy for Alunbrig compared to Pfizer's Xalkori, especially in patients with brain metastasis.
Takeda Biopharmaceutical to Donate $4.7M to Global Coronavirus Testing Initiative
Takeda's financial contribution will enable the International Atomic Energy Agency to ramp up its initiative to supply RT-PCR tests to laboratories globally.
Developers pointed to some success, but they also noted that more at-home tests need to demonstrate higher levels of performance and affordability.